Dataset of GWAS-identified variants underlying venous thromboembolism susceptibility and linkage to cancer aggressiveness (original) (raw)

Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?

Ozlem Er Civelek

Asia-Pacific Journal of Clinical Oncology, 2012

View PDFchevron_right

Venous thromboembolism and Cancer

Guilherme Yazbek

Springer eBooks, 2022

View PDFchevron_right

Cancer and venous thromboembolism

Marcus Stoodley

American Heart Journal, 1996

View PDFchevron_right

Venous Thromboembolic Disease and Cardio Oncology

Konstantinos Panagiotopoulos

Open access journal of cardiology, 2018

View PDFchevron_right

Prothrombotic genotypes and risk of venous thromboembolism in cancer

Søren Kristensen

Thrombosis Research, 2018

View PDFchevron_right

Current perspectives on primary prophylaxis and patient risk factors for venous thromboembolism in the cancer patient

Howard Liebman

Cancer control : journal of the Moffitt Cancer Center, 2005

View PDFchevron_right

2019 International Clinical Practice Guidelines for the Treatment and Prophylaxis of Venous Thromboembolism in Patients with Cancer

C. Guillermo

The Lancet Oncology, 2019

View PDFchevron_right

Thrombosis-Related DNA Polymorphisms

Balkiss Abdelmoula

Genetic Polymorphisms - New Insights, 2022

View PDFchevron_right

Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients

Umberto Nanni

Medical Decision Making, 2016

View PDFchevron_right

Faculty of 1000 evaluation for Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014

Jeffrey Weitz

F1000 - Post-publication peer review of the biomedical literature

View PDFchevron_right

Is Genetic Screening Necessary for Determining the Possibility of Venous Thromboembolism in Cancer Patients?

Ahmet Var

Medical Principles and Practice, 2012

View PDFchevron_right

Cancer-Associated Thrombosis: A Clinical Scoping Review of the Risk Assessment Models Across Solid Tumours and Haematological Malignancies

Mohamed Elnaem

International Journal of General Medicine, 2021

View PDFchevron_right

Venous Thromboembolism

Thomas Hyers

American Journal of Respiratory and Critical Care Medicine, 1999

View PDFchevron_right

Gene variants associated with venous thrombosis: confirmation in the MEGA study

James C Devlin

Journal of Thrombosis and Haemostasis, 2010

View PDFchevron_right

Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis

Andrew Brown

Human Molecular Genetics, 2016

View PDFchevron_right

Risk of Venous Thromboembolism

Ursula Gundert-remy

Deutsches Arzteblatt International, 2011

View PDFchevron_right

Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

Selma Raymundo

Journal of Thrombosis and Thrombolysis, 2020

View PDFchevron_right

Prevalence of Factor V 1691 G–A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients

nejat akar

Journal of Thrombosis and Thrombolysis, 2007

View PDFchevron_right

Differential biomarker profiles between unprovoked venous thromboembolism and cancer

Remedios Otero Candelera

Annals of Medicine, 2020

View PDFchevron_right

Inherited Thrombophilia and Risk of Thrombosis in Children with Cancer: a Single-center Experience

Blaženka Grahovac

Acta Medica Academica, 2024

View PDFchevron_right

Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism

John Heit

Thrombosis research, 2015

View PDFchevron_right

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

Yana Nuryana

British journal of cancer, 2018

View PDFchevron_right

Risk for venous thromboembolic events in patients with advanced urinary tract cancer treated with 1st-line chemotherapy

Christos Alamanis

Clinical Genitourinary Cancer, 2020

View PDFchevron_right

Epidemiology, risk and outcomes of venous thromboembolism in cancer

Anna Falanga

Hämostaseologie, 2012

View PDFchevron_right

Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer

Alok Khorana

Journal of Thrombosis and Haemostasis, 2008

View PDFchevron_right

Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies

Federica Grosso

British journal of cancer, 2012

View PDFchevron_right

Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism

Brenda S. Garcia

American Journal of Clinical Oncology, 2019

View PDFchevron_right

Mutations in Promoter Region of Thrombomodulin and Venous Thromboembolic Disease

sophie gandrille

Arteriosclerosis, Thrombosis, and Vascular Biology, 1999

View PDFchevron_right

Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry)

Mitsuru Sasako

BMJ Open, 2018

View PDFchevron_right

HIV Infection Is a Risk Factor for Venous Thromboembolism

Ahmet Copur

Aids Patient Care and Stds, 2002

View PDFchevron_right

Prothrombin A19911G and G20210A polymorphisms' role in thrombosis

Ignacio Alberca

British Journal of Haematology, 2002

View PDFchevron_right

Genetic risk factors for venous thromboembolism

Bengt Zoller

Expert Review of Hematology, 2020

View PDFchevron_right

Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors

Maris Teder-Laving

Circulation

View PDFchevron_right